microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. - Wikidata - wikimedia - TriplyDB

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.

http://www.wikidata.org/entity/Q37497239

about

miR-181a induces sorafenib resistance of hepatocellular carinoma cells through downregulation of RASSF1 expression An overview of long non-coding RNAs in ovarian cancers Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer EMT-Inducing Molecular Factors in Gynecological Cancers MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samples Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.Human aqueous humor exosomes.MicroRNA-181a is involved in the regulation of human endometrial stromal cell decidualization by inhibiting Krüppel-like factor 12 miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.An integrated network of microRNA and gene expression in ovarian cancer.Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma.LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.Therapeutic Opportunities for Targeting microRNAs in Cancer.miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1.MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.miRNA-target chimeras reveal miRNA 3'-end pairing as a major determinant of Argonaute target specificity Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.Epigallocatechin-3-O-gallate up-regulates microRNA-let-7b expression by activating 67-kDa laminin receptor signaling in melanoma cells.miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer Genome-Wide MicroRNA and Gene Analysis of Mesenchymal Stem Cell Chondrogenesis Identifies an Essential Role and Multiple Targets for miR-140-5p.miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4 miR-181a Induces Macrophage Polarized to M2 Phenotype and Promotes M2 Macrophage-mediated Tumor Cell Metastasis by Targeting KLF6 and C/EBPα.Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.Altered glutamine metabolism in platinum resistant ovarian cancer.MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.The expression and clinical significance of miR-132 in gastric cancer patients.

P2860

Q26744201-84793169-D516-4B2A-9705-DD0F4F6B0495 Q26753467-89DE21B6-AFED-4062-95A9-DB81B17B9162 Q26780387-8360B795-C5D2-4934-9DEB-B3CCFE95C56D Q26781912-EF1DC6FE-AF39-45A7-AF0D-AD0393B0F54B Q26822743-10A44FE7-E467-49C5-AE63-2A87A10352FA Q28077396-C13D4A09-FACF-4C9E-ACB2-D94838298825 Q30859743-CF97BBFD-1370-4443-9059-03E790A6DE48 Q33850074-A4ABAFDA-2758-4702-A69B-98F6C24FF5AB Q33872622-9048D529-8D84-481B-8D38-15C89A951884 Q33889122-17BF09BF-F2C9-4DD9-ABC2-1392AA2C54AE Q35050353-BCCC91D7-7D97-4177-A70E-6EE4D44F8B03 Q35125641-9E085522-F7D2-49B7-BD38-31ED46F125C5 Q35155865-785EFE17-0361-43B8-9C25-81D9373AEFDC Q35232769-0A4234C5-C129-4747-84F3-95FC6A017D6F Q35475330-A1DF64A6-5496-433A-B180-F770865CA22A Q35477129-80497264-A71C-487B-8A3C-9B0A3F21052B Q35550204-D1001EE7-3057-47DB-BAE1-18FC3CE905DF Q35666448-04C1C9AE-E190-4DCA-B41A-41E7CB25A946 Q35673914-A594A1A4-08F5-4CB1-8C7A-3837F2EEB65A Q35811902-63EDBBF3-EC5A-4141-8824-8B68CA63DB01 Q35813557-1D26901D-4F5A-4A4A-8602-39BE3CE2BEB2 Q36128575-34550A37-59B8-47BF-A73D-957C285359BD Q36150993-E3EFE39D-07F4-4B54-88F0-5CAF2D258FC7 Q36299135-F3FF664F-F168-414F-B0D6-995654335E23 Q36338901-87378037-3218-4403-A3A1-BE0F9F02C277 Q36340244-1452E6C6-CE8E-41FF-AD74-6AC7DBD51F1D Q36361054-0A3E0E1C-54CA-43B6-97D3-7255B7E19633 Q36414274-BC7913E3-17A0-446D-BAE5-750AC44EA300 Q36454002-9F981FCB-B932-4B21-A04E-C505E530DCEF Q36497625-BD073F88-9DFB-47D0-9009-4D86D11898AD Q36532581-FB1BEB26-B73E-466C-ABDB-2CB46EE34F40 Q36830338-111E0BA7-8B43-49A4-91A8-F98776396318 Q37046805-2FF5CA28-F3B4-464A-87F9-3DDC1492CC30 Q37321736-2BBE686C-C978-49BA-A4DA-EAE3205DB4DF Q37325088-2FFE8543-5F12-431A-868F-15518390BDDE Q37335617-0F397E33-BFAC-4644-8535-E3CDDE0F5EF0 Q37414561-BB6EC52B-0D32-4BD8-BD79-701D138ED9A5 Q37520321-67ED78DB-9A42-4C74-A732-9EF98501E708 Q37564379-3DF12C80-C12C-432C-ABF2-9FC5555B8693 Q37683714-0CA1E612-BDEE-460D-8A36-56CCDB0F57FC

P2860

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.

http://www.wikidata.org/entity/Q37497239

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

microRNA-181a has a critical r ...... helial-mesenchymal transition.

@en

microRNA-181a has a critical r ...... helial-mesenchymal transition.

@nl

type

label

microRNA-181a has a critical r ...... helial-mesenchymal transition.

@en

microRNA-181a has a critical r ...... helial-mesenchymal transition.

@nl

prefLabel

microRNA-181a has a critical r ...... helial-mesenchymal transition.

@en

microRNA-181a has a critical r ...... helial-mesenchymal transition.

@nl

P1433

Q37497239-B6AD79B7-4DDF-40F6-9E7C-726133D8A01D

P1476

Q37497239-FE3C3379-CD4B-4C72-B068-B7F3A6807BB3

P2093

Q37497239-104A8997-2E9F-438D-9A22-68BB3DC7CFC1

Q37497239-14CA9353-5320-4661-91FE-55EB35A4E9AD

Q37497239-1B9D72F0-7E14-4E3B-9D92-0E77382405D2

Q37497239-1F3197D3-18A3-461A-AE36-84BC0C0ABEC9

Q37497239-3EE3F089-9665-49B2-A669-DE4EF77EBE59

Q37497239-41418AB0-9BED-409F-860D-9D84B582F987

Q37497239-51F79A64-C8F3-421E-AC85-4B22F5369DD5

Q37497239-5529235D-998D-4A6D-8A77-8221FD1D27F9

Q37497239-5FA1CAA9-DE90-43CF-8167-757469DFA02D

Q37497239-6DD456E1-DF77-428D-B882-24D79A240881

P2860

Q37497239-11CF10B3-1C79-44D7-A8E1-169C8C1B7CFF

Q37497239-126DF106-7741-41BB-8328-5F757D7DB229

Q37497239-13CF6A71-4D46-4CEB-8D19-02ED9D47417A

Q37497239-1485A99A-6382-4D9E-9E76-EC58F5C8C47E

Q37497239-224A4F87-6074-4C63-B488-F575E10A000A

Q37497239-277169AC-B5DC-457A-A2ED-D0F9D4F582B4

Q37497239-285FA481-764A-45C4-8CFD-634A260D72CE

Q37497239-30CC0C15-9A59-4E2A-B09A-571B1037DE6B

Q37497239-3E14B09D-272D-4135-AE4F-54BA855268BE

Q37497239-4A9CD17C-BB89-42FC-9D96-7563889EF81B

P2888

Q37497239-3A9F47D3-F489-4E00-BDC3-2F7CDCB13B06

P304

Q37497239-5A46CF42-1938-4672-A050-4397139BE8A4

P31

Q37497239-4164B017-3709-49A8-A97F-E624310DE732

P356

Q37497239-D19065C1-8190-4813-8063-EDA15F34A671

P407

Q37497239-6A23823A-F5AF-4EE6-BFD4-83D452EB137E

P478

Q37497239-B130EAA0-D42D-4F19-94A0-5DE9ED36F605

P50

Q37497239-57CA839E-DFF2-4A2F-8DD7-E5B9FE965A12

Q37497239-6406D7B8-C28D-4650-8796-7469C862B3E1

Q37497239-896D5007-A7CD-4366-B13A-C980C792816D

Q37497239-B65F9E97-6B64-4285-831D-39637444A857

Q37497239-FB0B0F9B-82FE-4156-9EC5-8839879C7F1E

P577

Q37497239-51D3EA79-EC13-44C0-956E-E89189D87FE3

P5875

Q37497239-99F67A85-A2ED-494B-A6A8-15175E10BE39

P698

Q37497239-33FB34A3-320C-49FC-8593-885A72435ED6

P921

Q37497239-1E864A76-AA8E-4640-A0D9-C2BB32C0243A

Q37497239-6AA118FE-DA5A-4133-8177-2FB8CC5D3532

P932

Q37497239-BBCBD9A8-068F-4B1D-99D0-914DA592DCD3

P356

P1433

Nature Communications

P1476

microRNA-181a has a critical r ...... thelial-mesenchymal transition

@en

P2093

Aditya Parikh

http://www.w3.org/2001/XMLSchema#string

Alessia Baccarini

http://www.w3.org/2001/XMLSchema#string

Analisa DiFeo

http://www.w3.org/2001/XMLSchema#string

Brian D Brown

http://www.w3.org/2001/XMLSchema#string

Christine Lee

http://www.w3.org/2001/XMLSchema#string

David Fishman

http://www.w3.org/2001/XMLSchema#string

Feng Wang

http://www.w3.org/2001/XMLSchema#string

Gavriel Mullokandov

http://www.w3.org/2001/XMLSchema#string

Hardik Shah

http://www.w3.org/2001/XMLSchema#string

Jamal Rahaman

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

Integrated genomic analyses of ovarian carcinoma

Mammalian microRNAs predominantly act to decrease target mRNA levels

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

MicroRNA expression profiles classify human cancers

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

MicroRNA signatures in human ovarian cancer

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types

P2888

P304

2977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS3977

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio D'Incalci

Sergio Marchini

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259606903

http://www.w3.org/2001/XMLSchema#string

P698

24394555

http://www.w3.org/2001/XMLSchema#string

P921

P932

3896774

http://www.w3.org/2001/XMLSchema#string